Nima Nabavizadeh principal investigator for the PATHFINDER 2 study
Credit: OHSU News
Nima Nabavizadeh, M.D., a physician-scientist at OHSU Knight Cancer Institute, is principal investigator for the PATHFINDER 2 study. Results published in Nature Medicine show the GRAIL Galleri test the study is assessing dramatically improves multi-cancer early detection when used with routine screening. (OHSU/Christine Torres Hicks)